Engineered Mitochondrial Transplantation as An Anti-Aging Therapy

Area of Science:

• Gerontology and Regenerative Medicine
• Mitochondrial Biology and Therapeutics

Background:

• Aging is a complex biological process intrinsically linked to mitochondrial dysfunction, characterized by decreased mitochondrial quality and activity.
• Mitochondrial dysfunction contributes significantly to aging and the development of age-related diseases, making mitochondria a key therapeutic target.
• Current anti-aging strategies targeting mitochondria, such as senolytic drugs and antioxidants, may present long-term adverse effects.

Purpose of the Study:

• To introduce mitochondrial transplantation as a novel therapeutic strategy for mitigating aging and associated diseases.
• To review the current status and translational potential of mitochondrial transplantation in treating age-related conditions.

Main Methods:

• This review synthesizes existing research on mitochondrial transplantation, focusing on its application in aging.
• The review discusses the transfer of healthy mitochondria from donor cells to recipient cells to restore mitochondrial function.

Main Results:

• Mitochondrial transplantation has demonstrated successful applications in combating aging diseases, including neurodegenerative disorders, cardiovascular aging, and reproductive aging.
• The therapy highlights significant translational potential for clinical anti-aging interventions.

Conclusions:

• Mitochondrial transplantation presents a promising alternative to existing therapies for mitochondrial dysfunction and aging.
• Further research is needed to address the challenges and capitalize on the opportunities for mitochondrial transplantation in anti-aging therapy.